1. "Molecular Pharmacology and Chemistry Program Faculty"
Formats
  1. Journal Article (4957)
  2. Meeting Abstract (2007)
  3. Book Section (216)
  4. Conference Paper (122)
  5. Review (79)
  6. Editorial (48)
  7. Book Whole (28)
  8. Research Letter (15)
  9. Correspondence (8)
  10. Miscellaneous (6)
  11. Guidelines (1)
Groups
  1. Molecular Pharmacology and Chemistry Program Faculty (7487)
  2. Sloan Kettering Institute Faculty (7487)
  3. GSK Faculty (4697)
  4. Department of Medicine (2717)
  5. Surgery (2096)
  6. Center for Hematologic Malignancies (1819)

More Groups

People
  1. Murray Brennan (1059)
  2. Steven Larson (957)
  3. Peter Scardino (671)
  4. Michel Sadelain (582)
  5. Samuel Danishefsky (539)
  6. David Scheinberg (499)

More People

Years
  1. 2025 (36)
  2. 2024 (94)
  3. 2023 (122)
  4. 2022 (150)
  5. 2021 (154)
  6. 2020 (162)

More Years

Publications
  1. Journal of Nuclear Medicine (382)
  2. Blood (379)
  3. Cancer Research (340)
  4. Journal of Clinical Oncology (315)
  5. Annals of Surgical Oncology (181)
  6. International Journal of Radiation Oncology, Biology, Physics (176)

More Publications

Publishers
  1. American Association for Cancer Research (712)
  2. Elsevier Inc. (693)
  3. Nature Publishing Group (490)
  4. Springer (467)
  5. American Chemical Society (440)
  6. Elsevier Science, Inc. (405)

More Publishers

Results (7487)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Three-component coupling approach for the synthesis of diverse heterocycles utilizing reactive nitrilium trapping
    Journal Article

    Varadi, A.; Palmer, T. C.; Notis, P. R.; Redel-Traub, G. N.; Afonin, D.; Subrath, J. J.; Pasternak, G. W.; Hu, C.; Sharma, I.; Majumdar, S.
    Organic Letters (2014)

    Fulltext@MSK | Save
  • What is still needed to make focal therapy an accepted segment of standard therapy?
    Journal Article

    Van Den Bos, W.; Muller, B. G.; Ehdaie, B.; Scardino, P.; De La Rosette, J. J. M. C. H.
    Current Opinion in Urology (2014)

    Fulltext@MSK | Save
  • Heat shock protein 70 inhibitors. 2. 2,5′-thiodipyrimidines, 5-(phenylthio)pyrimidines, 2-(pyridin-3-ylthio)pyrimidines, and 3-(phenylthio)pyridines as reversible binders to an allosteric site on heat shock protein 70
    Journal Article

    Taldone, T.; Kang, Y.; Patel, H. J.; Patel, M. R.; Patel, P. D.; Rodina, A.; Patel, Y.; Gozman, A.; Maharaj, R.; Clement, C. C.; more...
    Journal of Medicinal Chemistry (2014)

    Fulltext@MSK | Save
  • Inhibition of human mitochondrial peptide deformylase causes apoptosis in c-myc-overexpressing hematopoietic cancers
    Journal Article

    Sheth, A.; Escobar-Alvarez, S.; Gardner, J.; Ran, L.; Heaney, M. L.; Scheinberg, D. A.
    Cell Death & Disease (2014)

    Fulltext@MSK | Save
  • From the Guest Editor: The rise of CAR therapy: The CD19 paradigm, and beyond
    Journal Article

    Sadelain, M.
    The Cancer Journal (2014)

    Fulltext@MSK | Save
  • Bone-seeking radiopharmaceuticals for treatment of osseous metastases, Part 1: α therapy with 223Ra-dichloride
    Journal Article

    Pandit-Taskar, N.; Larson, S. M.; Carrasquillo, J. A.
    Journal of Nuclear Medicine (2014)

    Fulltext@MSK | Save
  • Complete blood counts are frequently abnormal 1 year after dosimetry-guided radioactive iodine therapy for metastatic thyroid cancer
    Journal Article

    Padovani, R. P.; Tuttle, R. M.; Grewal, R.; Larson, S. M.; Boucai, L.
    Endocrine Practice (2014)

    Fulltext@MSK | Save
  • Heat shock protein 70 inhibitors. 1. 2,5′-thiodipyrimidine and 5-(phenylthio)pyrimidine acrylamides as irreversible binders to an allosteric site on heat shock protein 70
    Journal Article

    Kang, Y.; Taldone, T.; Patel, H. J.; Patel, P. D.; Rodina, A.; Gozman, A.; Maharaj, R.; Clement, C. C.; Patel, M. R.; Brodsky, J. L.; more...
    Journal of Medicinal Chemistry (2014)

    Fulltext@MSK | Save
  • Heat shock protein 90 inhibitors in the treatment of cancer: Current status and future directions
    Journal Article

    Jhaveri, K.; Ochiana, S. O.; Dunphy, M. P. S.; Gerecitano, J. F.; Corben, A. D.; Peter, R. I.; Janjigian, Y. Y.; Gomes DaGama, E. M.; Koren, J. 3rd; Modi, S.; more...
    Expert Opinion on Investigational Drugs (2014)

    Fulltext@MSK | Save
  • Csnk1a1 inhibition has p53-dependent therapeutic efficacy in acute myeloid leukemia
    Journal Article

    Järås, M.; Miller, P. G.; Chu, L. P.; Puram, R. V.; Fink, E. C.; Schneider, R. K.; Al-Shahrour, F.; Peña, P.; Breyfogle, L. J.; Hartwell, K. A.; more...
    Journal of Experimental Medicine (2014)

    Fulltext@MSK | Save